Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 3
1987 1
1989 1
1991 1
1992 3
1993 1
1994 2
1996 1
1997 1
1999 1
2000 1
2001 1
2003 1
2004 1
2005 2
2007 1
2008 2
2009 1
2010 1
2011 5
2012 5
2013 4
2014 6
2015 7
2016 7
2017 3
2018 5
2019 6
2020 10
2021 12
2022 14
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators. von Minckwitz G, et al. N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5. N Engl J Med. 2019. PMID: 30516102 Clinical Trial.
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Pharmacist-initiated antiretroviral therapy (PIMART).
Moodley S, Gray A, Schellack N, Schellack N, Venter F, Venter F, Suleman F, Suleman F, Walker RB, Walker RB, Choonara Y, Choonara Y, Truter I, Truter I, Maimin J, Maimin J, Malan SF, Malan SF, Hattingh J, Hattingh J, Meyer JC, Meyer JC, Demana P, Demana P, Kotzé I, Kotzé I, Kubashe N, Kubashe N, Komape TK, Komape TK, Van Wyk S, Van Wyk S, Eksteen M, Eksteen M. Moodley S, et al. S Afr Med J. 2021 Dec 2;111(12):1162-1163. doi: 10.7196/SAMJ.2021.v111i12.16262. S Afr Med J. 2021. PMID: 34949299 Free article. No abstract available.
Late-life depression and the family physician.
Moodley S, Maisto A. Moodley S, et al. S Afr Fam Pract (2004). 2022 Jun 28;64(1):e1-e4. doi: 10.4102/safp.v64i1.5534. S Afr Fam Pract (2004). 2022. PMID: 35792626 Free PMC article.
Ototoxicity: A review of South African studies.
Moodley S, Storbeck C, Gama N. Moodley S, et al. S Afr Fam Pract (2004). 2021 Mar 15;63(1):e1-e10. doi: 10.4102/safp.v63i1.5187. S Afr Fam Pract (2004). 2021. PMID: 33764142 Free PMC article. Review.
Immunologic and imaging signatures in post tuberculosis lung disease.
Singh S, Allwood BW, Chiyaka TL, Kleyhans L, Naidoo CC, Moodley S, Theron G, Segal LN. Singh S, et al. Among authors: moodley s. Tuberculosis (Edinb). 2022 Sep;136:102244. doi: 10.1016/j.tube.2022.102244. Epub 2022 Aug 11. Tuberculosis (Edinb). 2022. PMID: 36007338 Free PMC article. Review.
Narrative review of EHDI in South Africa.
Moodley S, Storbeck C. Moodley S, et al. S Afr J Commun Disord. 2015;62(1):E1-10. doi: 10.4102/sajcd.v62i1.126. S Afr J Commun Disord. 2015. PMID: 26809156 Free PMC article. Review.
118 results